89 related articles for article (PubMed ID: 5128423)
1. [Taurine in the therapy of obliterating arteriopathy of the lower extremities. II. Hemoximetric changes in various evolutive stages].
Zanelli G; Quaglia A; Zino P
Minerva Cardioangiol; 1971 Nov; 19(11):616-9. PubMed ID: 5128423
[No Abstract] [Full Text] [Related]
2. [Taurine in the therapy of obliterating arteriopathy of the lower extremities. I. Clinical results in various evolutive phases].
Zanelli G; Ferrero S; Patrone P
Minerva Cardioangiol; 1971 Nov; 19(11):605-15. PubMed ID: 5128422
[No Abstract] [Full Text] [Related]
3. [The results of the drug therapy of the ischemic syndrome in arteriosclerosis obliterans].
Prokhorov GG; Potapov VV; Ogneva NS; Zybina NN
Vestn Khir Im I I Grek; 1994; 152(1-2):30-4. PubMed ID: 7701736
[TBL] [Abstract][Full Text] [Related]
4. [On the use of injectable crataegus extracts in therapy of disorders of peripheral arterial circulation in subjects with obliterating arteriopathy of the lower extremities].
Di Renzi L; Cassone R; Lucisano V; Leggio F; Gambelli G
Boll Soc Ital Cardiol; 1969; 14(4):577-85. PubMed ID: 5408200
[No Abstract] [Full Text] [Related]
5. [Chorionic gonadotropin (HCG) in the therapy of chronic peripheral obliterating arteriopathy (CPOA) of the lower extremities caused by arteriosclerosis].
Bonandrini L; Mantellini E; Colombo P; Seghezzi R; Lombardo F
Minerva Chir; 1970 Mar; 25(5):368-83. PubMed ID: 5438397
[No Abstract] [Full Text] [Related]
6. [A trial of the use of Vasaprostan in patients with arteriosclerosis obliterans of the lower extremities].
Lebedev LV; Dobrynin EV; Luk'ianov IuV; Ignat'ev EI; Afonin DN
Vestn Khir Im I I Grek; 1993; 150(5-6):151-3. PubMed ID: 8091568
[No Abstract] [Full Text] [Related]
7. [Effects of suloctidil therapy on platelet function in patients with on obliterating arteriopathy of the lower limbs].
Davì G; Pinto A; Novo S; Avellone G; Galati D; Mazzola A
Clin Ter; 1982 Oct; 103(2):131-7. PubMed ID: 6295693
[No Abstract] [Full Text] [Related]
8. [Ways to enhance the efficacy of treating patients with the terminal stage of arterial ischemia of the lower extremities].
Lebedev LV; Afonin DN
Vestn Khir Im I I Grek; 1995; 154(1):54-7. PubMed ID: 7792994
[TBL] [Abstract][Full Text] [Related]
9. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
Blasi A; Licciardello M
Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194
[No Abstract] [Full Text] [Related]
10. [Treatment of chronic cerebrovascular insufficiency and chronic obliterating arteriopathy of the lower extremities with buflomedil hydrochloride].
Salerno L; Sallì L; Pepe S; Curiale B; Allegra G; Scalici G; Salvato F
Minerva Med; 1985 Sep; 76(36):1611-8. PubMed ID: 4047447
[TBL] [Abstract][Full Text] [Related]
11. [Results of adrenalectomy and lumbar ganglionectomy in the therapy of chronic peripheral obliterating arteriopathy (C.P.O.A.) of the lower extremities].
Guagliano G; Vittori C; Maurizio A; Taborelli R
Minerva Chir; 1967 Feb; 22(4):159-70. PubMed ID: 6050194
[No Abstract] [Full Text] [Related]
12. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
Duthois S; Cailleux N; Lévesque H
J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
[TBL] [Abstract][Full Text] [Related]
13. [The association of kallikrein and inositol hexanicotinate in the therapy of peripheral obliterating arteriopathy].
D'Ayala Valva G
Recenti Prog Med; 1966 Jun; 40(6):XIX-XXXVI. PubMed ID: 6014405
[No Abstract] [Full Text] [Related]
14. [An assessment of the efficacy of intravenous monotherapy with the preparation solcoseryl in patients with arteriosclerosis obliterans of the vessels of the lower extremities].
Luk'ianov IuV; Shlomin VV; Sokurenko GIu; Didenko IuP; Orlov NN; Kondrat'ev VM; Batalin IV
Vestn Khir Im I I Grek; 2000; 159(3):81-4. PubMed ID: 10983350
[TBL] [Abstract][Full Text] [Related]
15. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
Seghezzi R; Pedroni G; Borri P
Chir Ital; 1967; 19():Suppl 2:222+. PubMed ID: 5190600
[No Abstract] [Full Text] [Related]
16. [Behavior and significance of beta-thromboglobulin in chronic obliterating arteriopathy of the lower limbs. Preliminary research].
Binaghi F; Valle E; Manconi E; Pitzus F
Cardiologia; 1982 Nov; 27(11):1043-9. PubMed ID: 6085827
[No Abstract] [Full Text] [Related]
17. [Experience with treatment of obliterating atherosclerosis of the lower extremities with vitamin A and E under ambulatory conditions].
Nechaev EB
Vrach Delo; 1966 May; 5():128-9. PubMed ID: 5995479
[No Abstract] [Full Text] [Related]
18. [Use of the sulfonic ester of adrenochrome semicarbazone in the therapy of phlebopathies and obliterating arteriosclerotic arteriopathies of the lower extremities].
Seghezzi R; Pedroni G; Ercoli A
Chir Ital; 1967; 19():Suppl 2:349+. PubMed ID: 5190607
[No Abstract] [Full Text] [Related]
19. [Changes in muscular and cutaneous blood flow induced by posture changes in subjects with obliterating arteriopathy of the lower extremities].
Condorelli S; Colombati M; Montori A
Boll Soc Ital Biol Sper; 1965 Apr; 41(7):380-2. PubMed ID: 5876145
[No Abstract] [Full Text] [Related]
20. [Intra-arterial infusion in the treatment of severe forms of occlusive vascular diseases of the lower limbs].
Lytkin MI; Nazarov GD; Barinov VS
Vestn Khir Im I I Grek; 1981 Jan; 126(1):78-82. PubMed ID: 7222426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
